Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Meta IMD Test

Metabolon has launched Meta IMD through its CLIA laboratory-developed test. The test identifies hundreds of metabolites associated with a wide range of inherited metabolic disorders — including developmental delay, seizures, low blood sugar, or speech and/or language delay — from a small plasma sample. A 250 microliter plasma sample provides specific information to assist the physician in deciding what additional clinical tests are needed to confirm or clarify a diagnosis, the company said. Results are typically delivered in about 21 days.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.